Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.
Multiple sclerosis (Houndmills, Basingstoke, England)·2010
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS study.
Multiple sclerosis (Houndmills, Basingstoke, England)·2005
Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy.
Multiple sclerosis (Houndmills, Basingstoke, England)·2003
Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitis.
Multiple sclerosis (Houndmills, Basingstoke, England)·2003
The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis.
Journal of neuroimmunology·2001